CHEK2 and breast cancer: Since P/LPs variants in BRCA1, BRCA2, CHEK2, or PALB2 substantially increase the risk of contralateral BC, the patients may benefit from additional aggressive surveillance specifically for contralateral BC with supplemental magnetic resonance imaging (MRI) and mammograms, as per international guidelines48.